Novo’s Wegovy® (semaglutide) reduced liver fat to normal levels in 9 out of 10 adults with obesity and excess liver fat – EASD2026

Migma AI turns this inspiration into an email with your brand’s colors, fonts, and voice.

Create this for my brand

Novo’s Wegovy® (semaglutide) reduced liver fat to normal levels in 9 out of 10 adults with obesity and excess liver fat – EASD2026 email from Novo Nordisk screenshot

Make this email yours.

Design observations

Novo Nordisk announces clinical trial results showing Wegovy reduces liver fat in adults with obesity.

Visual structure

Simple text-heavy layout featuring a corporate logo at the top left, followed by dense press release text, bullet points, quotes, contact details, and references.

Email details

Captured: October 1, 2026
Email type: Announcement
Industry: Vitamins & Nutrition
AI design score: 3/10
Language: English
Tone: Professional
Style: Text-heavy
Journey stage: Consideration
CTA count: 1
Animated GIF: No
Dark mode: No

Color palette

How does Migma learn my brand?

Import your website in Migma, then review your logo, colors, fonts, and brand voice. AI uses those settings and your brief to create an editable email. See how brand setup works.

Was this example made with Migma AI?

This is an archived brand email, shown for inspiration. The archive does not establish how it was made. Remixing starts a new email for your own brand.

What can I download or export?

Download preview saves an image of this example. Export HTML downloads its original source on a paid plan, subject to daily limits. You can also edit and export the new email you create in Migma. View plans.

Archived for design inspiration. Original email and brand assets belong to their respective owners. Design observations describe the creative; they are not campaign results.